UniProt ID | GHR_HUMAN | |
---|---|---|
UniProt AC | P10912 | |
Protein Name | Growth hormone receptor | |
Gene Name | GHR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 638 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. On growth hormone binding, GHR is ubiquitinated, internalized, down-regulated and transported into a degradative or non-degradative pathway.. Isoform 2: Cell membrane Single-pass type I membrane p |
|
Protein Description | Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity).; The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling.; Isoform 2 up-regulates the production of GHBP and acts as a negative inhibitor of GH signaling.. | |
Protein Sequence | MDLWQLLLTLALAGSSDAFSGSEATAAILSRAPWSLQSVNPGLKTNSSKEPKFTKCRSPERETFSCHWTDEVHHGTKNLGPIQLFYTRRNTQEWTQEWKECPDYVSAGENSCYFNSSFTSIWIPYCIKLTSNGGTVDEKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAPRNADIQKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYGEFSEVLYVTLPQMSQFTCEEDFYFPWLLIIIFGIFGLTVMLFVFLFSKQQRIKMLILPPVPVPKIKGIDPDLLKEGKLEEVNTILAIHDSYKPEFHSDDSWVEFIELDIDEPDEKTEESDTDRLLSSDHEKSHSNLGVKDGDSGRTSCCEPDILETDFNANDIHEGTSEVAQPQRLKGEADLLCLDQKNQNNSPYHDACPATQQPSVIQAEKNKPQPLPTEGAESTHQAAHIQLSNPSSLSNIDFYAQVSDITPAGSVVLSPGQKNKAGMSQCDMHPEMVSLCQENFLMDNAYFCEADAKKCIPVAPHIKVESHIQPSLNQEDIYITTESLTTAAGRPGTGEHVPGSEMPVPDYTSIHIVQSPQGLILNATALPLPDKEFLSSCGYVSTDQLNKIMP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
30 | O-linked_Glycosylation | EATAAILSRAPWSLQ HHHHHHHHCCCCCCC | 21.93 | OGP | |
46 | N-linked_Glycosylation | VNPGLKTNSSKEPKF CCCCCCCCCCCCCCC | 42.57 | UniProtKB CARBOHYD | |
76 | Phosphorylation | TDEVHHGTKNLGPIQ ECCCCCCCCCCCCEE | 16.65 | - | |
115 | N-linked_Glycosylation | GENSCYFNSSFTSIW CCCCCCCCCCCCEEE | 15.40 | UniProtKB CARBOHYD | |
156 | N-linked_Glycosylation | PDPPIALNWTLLNVS CCCCEECCEEEEEEE | 22.21 | UniProtKB CARBOHYD | |
161 | N-linked_Glycosylation | ALNWTLLNVSLTGIH ECCEEEEEEEECCCC | 25.17 | UniProtKB CARBOHYD | |
200 | N-linked_Glycosylation | ELQYKEVNETKWKMM EEEECCCCCCCCEEC | 52.92 | UniProtKB CARBOHYD | |
218 | Phosphorylation | LTTSVPVYSLKVDKE CCCCCEEEEEECCCE | 11.38 | - | |
219 | Phosphorylation | TTSVPVYSLKVDKEY CCCCEEEEEECCCEE | 23.19 | 24719451 | |
224 | Ubiquitination | VYSLKVDKEYEVRVR EEEEECCCEEEEEEE | 66.25 | - | |
226 | Phosphorylation | SLKVDKEYEVRVRSK EEECCCEEEEEEEEC | 26.01 | - | |
288 | Phosphorylation | MLFVFLFSKQQRIKM HHHHHHHCCCCCEEE | 31.53 | 24719451 | |
324 | Phosphorylation | GKLEEVNTILAIHDS CCHHHHHEEEEEECC | 23.65 | 22210691 | |
331 | Phosphorylation | TILAIHDSYKPEFHS EEEEEECCCCCCCCC | 22.39 | 24275569 | |
332 | Phosphorylation | ILAIHDSYKPEFHSD EEEEECCCCCCCCCC | 36.30 | 9121492 | |
341 | Phosphorylation | PEFHSDDSWVEFIEL CCCCCCCCCEEEEEE | 37.70 | 8421103 | |
357 | Phosphorylation | IDEPDEKTEESDTDR CCCCCCCCCCCHHHH | 42.83 | - | |
367 | Phosphorylation | SDTDRLLSSDHEKSH CHHHHHHCCCCHHHH | 38.01 | 22817900 | |
368 | Phosphorylation | DTDRLLSSDHEKSHS HHHHHHCCCCHHHHC | 42.85 | 22817900 | |
373 | Phosphorylation | LSSDHEKSHSNLGVK HCCCCHHHHCCCCCC | 29.21 | 26437602 | |
375 | Phosphorylation | SDHEKSHSNLGVKDG CCCHHHHCCCCCCCC | 40.62 | 26437602 | |
487 | Phosphorylation | SLSNIDFYAQVSDIT HHCCCEEEEEECCCC | 7.74 | 9121492 | |
534 | Phosphorylation | NFLMDNAYFCEADAK CCCCCCEEEECCCHH | 18.28 | 8647880 | |
566 | Phosphorylation | SLNQEDIYITTESLT CCCCCCEEEEEHHHH | 12.44 | 8647880 | |
595 | Phosphorylation | SEMPVPDYTSIHIVQ CCCCCCCCCEEEEEE | 9.05 | - | |
627 | Phosphorylation | EFLSSCGYVSTDQLN HHHHHCCCCCHHHHH | 8.78 | 8647880 | |
629 | Phosphorylation | LSSCGYVSTDQLNKI HHHCCCCCHHHHHHC | 20.13 | 27251275 | |
630 | Phosphorylation | SSCGYVSTDQLNKIM HHCCCCCHHHHHHCC | 20.09 | 27251275 | |
637 | Phosphorylation | TDQLNKIMP------ HHHHHHCCC------ | 3.26 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
332 | Y | Phosphorylation | Kinase | JAK2 | O60674 | PhosphoELM |
487 | Y | Phosphorylation | Kinase | JAK2 | O60674 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | SOCS2 | O14508 | PMID:21980433 |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:23607312 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GHR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GHR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SGTA_HUMAN | SGTA | physical | 12735788 | |
JAK2_HUMAN | JAK2 | physical | 7540178 | |
CISH_HUMAN | CISH | physical | 10585430 | |
SOCS1_HUMAN | SOCS1 | physical | 10585430 | |
SOCS3_HUMAN | SOCS3 | physical | 10585430 | |
SOCS2_HUMAN | SOCS2 | physical | 10585430 | |
STAT3_HUMAN | STAT3 | physical | 8923468 | |
STA5B_HUMAN | STAT5B | physical | 8923468 | |
JAK2_HUMAN | JAK2 | physical | 8063815 | |
JAK1_HUMAN | JAK1 | physical | 10502458 | |
JAK2_HUMAN | JAK2 | physical | 10502458 | |
TYK2_HUMAN | TYK2 | physical | 10502458 | |
PTN2_HUMAN | PTPN2 | physical | 12907755 | |
PTPRB_HUMAN | PTPRB | physical | 12907755 | |
PTN1_HUMAN | PTPN1 | physical | 12907755 | |
DUS7_HUMAN | DUSP7 | physical | 12907755 | |
PTN9_HUMAN | PTPN9 | physical | 12907755 | |
PTN3_HUMAN | PTPN3 | physical | 12907755 | |
PTN13_HUMAN | PTPN13 | physical | 12907755 | |
CHIP_HUMAN | STUB1 | physical | 22433856 | |
JAK2_HUMAN | JAK2 | physical | 21347402 | |
SOCS2_HUMAN | SOCS2 | physical | 12135564 | |
SKP1_HUMAN | SKP1 | physical | 23607312 | |
FBW1A_HUMAN | BTRC | physical | 23607312 | |
GHR_HUMAN | GHR | physical | 24280222 | |
FBW1B_HUMAN | FBXW11 | physical | 24280222 | |
JAK2_HUMAN | JAK2 | physical | 24280222 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00254 | Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defe | |||||
OMIM Disease | ||||||
262500 | Laron syndrome (LARS) | |||||
604271 | Growth hormone insensitivity, partial (GHIP) | |||||
Kegg Drug | ||||||
D02691 | Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Somatropin (USP/INN); Asella | |||||
D05394 | Pegvisomant (genetical recombination) (JAN); Pegvisomant (USAN/INN); Somavent (TN) | |||||
D05884 | Somatrem (genetical recombination) (JAN); Somatrem (USAN); Protropin (TN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...